TERM ID="NYU_TERM_1" STRING="Adenovirus" FREQUENCY=1 START=78 END=88 LEMMA="ADENOVIRUS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="Bolstering Components" FREQUENCY=1 START=0 END=21 LEMMA="BOLSTERING COMPONENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="Bolstering Components of the Immune Response" FREQUENCY=1 START=0 END=44 LEMMA="IMMUNE RESPONSE BOLSTERING COMPONENT" LEMMA_FREQUENCY=1 HEAD_TERM="Bolstering Components" HEAD_LEMMA="BOLSTERING COMPONENT"
TERM ID="NYU_TERM_4" STRING="Ebola" FREQUENCY=1 START=493 END=498 LEMMA="EBOLA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="Ebola outbreak" FREQUENCY=1 START=189 END=203 LEMMA="EBOLA OUTBREAK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="F16" FREQUENCY=4 START=771 END=774 LEMMA="F16" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_7" STRING="F16" FREQUENCY=4 START=982 END=985 LEMMA="F16" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_8" STRING="F16" FREQUENCY=4 START=1207 END=1210 LEMMA="F16" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_9" STRING="F16" FREQUENCY=4 START=1409 END=1412 LEMMA="F16" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_10" STRING="FW" FREQUENCY=1 START=776 END=778 LEMMA="FW" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="Guided Formulation Development" FREQUENCY=1 START=90 END=120 LEMMA="GUIDED FORMULATION DEVELOPMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="Guided Formulation Development for a Nasal Ebola Vaccine" FREQUENCY=1 START=90 END=146 LEMMA="NASAL EBOLA VACCINE GUIDED FORMULATION DEVELOPMENT" LEMMA_FREQUENCY=1 HEAD_TERM="Guided Formulation Development" HEAD_LEMMA="GUIDED FORMULATION DEVELOPMENT"
TERM ID="NYU_TERM_13" STRING="Histochemical analysis" FREQUENCY=1 START=1155 END=1177 LEMMA="HISTOCHEMICAL ANALYSIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="IL-2" FREQUENCY=1 START=1517 END=1521 LEMMA="IL-2" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="Immune Response" FREQUENCY=1 START=29 END=44 LEMMA="IMMUNE RESPONSE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="Multiparameter flow" FREQUENCY=1 START=1365 END=1384 LEMMA="MULTIPARAMETER FLOW" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="NAB" FREQUENCY=1 START=884 END=887 LEMMA="NEUTRALIZING ANTIBODIES" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="ND50" FREQUENCY=1 START=945 END=949 LEMMA="ND50" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="Nasal Ebola Vaccine" FREQUENCY=1 START=127 END=146 LEMMA="NASAL EBOLA VACCINE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="PEG" FREQUENCY=1 START=1067 END=1070 LEMMA="PERCUTANEOUS ENDOSCOPIC GASTROSTOMY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="PEI" FREQUENCY=2 START=581 END=584 LEMMA="PRE EXISTING IMMUNITY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_22" STRING="PEI" FREQUENCY=2 START=1601 END=1604 LEMMA="PRE EXISTING IMMUNITY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_23" STRING="PLGA" FREQUENCY=1 START=1132 END=1136 LEMMA="PLGA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="T cells" FREQUENCY=1 START=1477 END=1484 LEMMA="T CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="TNF-α" FREQUENCY=1 START=1527 END=1532 LEMMA="TUMOUR NECROSIS FACTOR ALPHA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="ability" FREQUENCY=1 START=703 END=710 LEMMA="ABILITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="adenovirus (rAd)-based vaccines" FREQUENCY=1 START=402 END=433 LEMMA="ADENOVIRUS (RAD)-BASED VACCINE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="amphiphilic polymer" FREQUENCY=1 START=750 END=769 LEMMA="AMPHIPHILIC POLYMER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="anti-Ad" FREQUENCY=1 START=851 END=858 LEMMA="ANTI-AD" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_30" STRING="antibodies" FREQUENCY=1 START=872 END=882 LEMMA="ANTIBODY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_31" STRING="at-risk populations" FREQUENCY=1 START=270 END=289 LEMMA="AT-RISK POPULATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="concentrations" FREQUENCY=1 START=892 END=906 LEMMA="CONCENTRATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="fast-acting" FREQUENCY=1 START=229 END=240 LEMMA="FAST-ACTING" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="formulations" FREQUENCY=3 START=645 END=657 LEMMA="FORMULATION" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_35" STRING="formulations" FREQUENCY=3 START=1616 END=1628 LEMMA="FORMULATION" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_36" STRING="formulations" FREQUENCY=3 START=1810 END=1822 LEMMA="FORMULATION" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_37" STRING="immunization" FREQUENCY=2 START=514 END=526 LEMMA="IMMUNIZATION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_38" STRING="immunization" FREQUENCY=2 START=1351 END=1363 LEMMA="IMMUNIZATION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_39" STRING="immunological requirements" FREQUENCY=1 START=1710 END=1736 LEMMA="IMMUNOLOGICAL REQUIREMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_40" STRING="influenza virus" FREQUENCY=1 START=1910 END=1925 LEMMA="INFLUENZA VIRUS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_41" STRING="medical personnel" FREQUENCY=1 START=291 END=308 LEMMA="MEDICAL PERSONNEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_42" STRING="naive mice" FREQUENCY=1 START=1261 END=1271 LEMMA="NAIVE MOUSE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_43" STRING="nasal cavity" FREQUENCY=1 START=1321 END=1333 LEMMA="NASAL CAVITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_44" STRING="neutralization" FREQUENCY=1 START=731 END=745 LEMMA="NEUTRALIZATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_45" STRING="neutralizing antibodies" FREQUENCY=1 START=859 END=882 LEMMA="NEUTRALIZING ANTIBODY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_46" STRING="poly(ethylene) glycol" FREQUENCY=2 START=1044 END=1065 LEMMA="POLY(ETHYLENE) GLYCOL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_47" STRING="poly(ethylene) glycol" FREQUENCY=2 START=1044 END=1065 LEMMA="POLY(ETHYLENE) GLYCOL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_48" STRING="poly(lactic-co-glycolic) acid" FREQUENCY=1 START=1101 END=1130 LEMMA="POLY(LACTIC-CO-GLYCOLIC) ACID" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_49" STRING="polyfunctional antigen-specific CD8" FREQUENCY=1 START=1440 END=1475 LEMMA="POLYFUNCTIONAL ANTIGEN-SPECIFIC CD8" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_50" STRING="polymeric beads" FREQUENCY=1 START=1138 END=1153 LEMMA="POLYMERIC BEAD" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_51" STRING="pre-existing immunity" FREQUENCY=1 START=558 END=579 LEMMA="PRE-EXISTING IMMUNITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_52" STRING="producing IFN-γ" FREQUENCY=1 START=1500 END=1515 LEMMA="PRODUCING IFN-Γ" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_53" STRING="rAd" FREQUENCY=2 START=722 END=725 LEMMA="RECOMBINANT ADENOVIRUS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_54" STRING="rAd" FREQUENCY=2 START=975 END=978 LEMMA="RECOMBINANT ADENOVIRUS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_55" STRING="repeated prime-boost regimens" FREQUENCY=1 START=336 END=365 LEMMA="REPEATED PRIME-BOOST REGIMEN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_56" STRING="rural villagers" FREQUENCY=1 START=313 END=328 LEMMA="RURAL VILLAGER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_57" STRING="test formulations" FREQUENCY=1 START=1544 END=1561 LEMMA="TEST FORMULATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_58" STRING="transgene expression" FREQUENCY=2 START=811 END=831 LEMMA="TRANSGENE EXPRESSION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_59" STRING="transgene expression" FREQUENCY=2 START=1237 END=1257 LEMMA="TRANSGENE EXPRESSION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_60" STRING="ubiquitous pathogens" FREQUENCY=1 START=1868 END=1888 LEMMA="UBIQUITOUS PATHOGEN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_61" STRING="unformulated virus" FREQUENCY=1 START=1004 END=1022 LEMMA="UNFORMULATED VIRUS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_62" STRING="vaccine platforms" FREQUENCY=1 START=1833 END=1850 LEMMA="VACCINE PLATFORM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_63" STRING="vitro assay" FREQUENCY=1 START=681 END=692 LEMMA="VITRO ASSAY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_64" STRING="vivo performance" FREQUENCY=1 START=955 END=971 LEMMA="VIVO PERFORMANCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_65" STRING="vivo performance of rAd" FREQUENCY=1 START=955 END=978 LEMMA="RECOMBINANT ADENOVIRUS VIVO PERFORMANCE" LEMMA_FREQUENCY=1 HEAD_TERM="vivo performance" HEAD_LEMMA="VIVO PERFORMANCE"
